CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 96 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $736,000 | +1.8% | 71,478 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $723,000 | -0.3% | 71,478 | +10.8% | 0.00% | 0.0% |
| Q2 2016 | $725,000 | -5.1% | 64,532 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | -26.5% | 55,931 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,040,000 | +1.9% | 54,822 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | +26.2% | 54,379 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $809,000 | +3945.0% | 54,338 | +3949.0% | 0.00% | – |
| Q1 2015 | $20,000 | +33.3% | 1,342 | +21.3% | 0.00% | – |
| Q4 2014 | $15,000 | +7.1% | 1,106 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | +27.3% | 1,106 | +3.8% | 0.00% | – |
| Q2 2014 | $11,000 | -95.2% | 1,066 | -93.7% | 0.00% | – |
| Q1 2014 | $229,000 | – | 17,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |